logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Prime Medicine Appoints Allan Reine, M.D. As CEO

May 19, 2025•7 months ago

Company

Prime Medicine

CambridgeBiotechnology

Description

Prime Medicine has appointed Chief Financial Officer Allan Reine, M.D. as the new CEO following the resignation of Keith Gottesdiener, M.D. The appointment comes amid the company's decision to shelve its clinical-stage genetic medicine and lay off a number of staff.

Company Information

Company

Prime Medicine

Location

Cambridge, Massachusetts, United States

About

Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Taken together, Prime Editing’s versatile gene editing capabilities could unlock opportunities across thousands of potential indications.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months